Open access
Open access
Powered by Google Translator Translator

Cardiology (all articles)

Lamotrigine May Increase Risk for Heart Arrhythmias, FDA Warns

5 Apr, 2021 | 01:12h | UTC

Lamotrigine May Increase Risk for Heart Arrhythmias, FDA Warns – NEJM Journal Watch

FDA Safety Communication: Lamictal (lamotrigine): Drug Safety Communication – Studies Show Increased Risk of Heart Rhythm Problems in Patients with Heart Disease

Related commentary: Epileptologists Push Back on FDA’s New Cardiac Warning for Lamotrigine – Neurology Today

 


Cohort Study: DOACs Safe, Effective in Subset of Valvular AF Patients

5 Apr, 2021 | 01:10h | UTC

DOACs Safe, Effective in Subset of Valvular AF Patients – TCTMD

Original study: Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation: A Population-Based Cohort Study – Annals of Internal Medicine

 


RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients

1 Apr, 2021 | 03:32h | UTC

Effects of a reduced-sodium added-potassium salt substitute on blood pressure in rural Indian hypertensive patients: a randomized, double-blind, controlled trial – American Journal of Clinical Nutrition

Commentary: Salt substitution — an effective way to reduce blood pressure in rural India – The George Institute for Global Health

 

Commentaries on Twitter

 


M-A: Efficacy and safety of low-dose colchicine in patients with coronary disease

31 Mar, 2021 | 03:11h | UTC

Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials – European Heart Journal (link to abstract – $ for full-text)

 


Review and Algorithm: Tuberculosis and the Heart

31 Mar, 2021 | 03:07h | UTC

Tuberculosis and the Heart – Journal of the American Heart Association

 

Commentary on Twitter

 


AHA Scientific Statement | Adverse Pregnancy Outcomes and Cardiovascular Disease Risk

30 Mar, 2021 | 03:08h | UTC

Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association – Circulation

News Release: Six pregnancy complications are among red flags for heart disease later in life – American Heart Association

 


Troponin Testing in Patients With Supraventricular Tachycardia—Are We Overtesting? A Teachable Moment

30 Mar, 2021 | 03:07h | UTC

Troponin Testing in Patients With Supraventricular Tachycardia—Are We Overtesting? A Teachable Moment – JAMA Internal Medicine (free for a limited period)

Invited Commentary: Updating Our Thinking on Troponin Use and Interpretation (free for a limited period)

 


Analysis of conflicts of interest among authors and researchers of European clinical guidelines in cardiovascular medicine

30 Mar, 2021 | 02:53h | UTC

Analysis of conflicts of interest among authors and researchers of European clinical guidelines in cardiovascular medicine – Clinical Medicine Journal

 

Commentary on Twitter (thread – click for more)

 


Controversies in revascularization for stable coronary artery disease

30 Mar, 2021 | 02:49h | UTC

Controversies in revascularisation for stable coronary artery disease – Clinical Medicine Journal

 


The management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: key points from the ESC 2020 Clinical Practice Guidelines for the general and emergency physician

30 Mar, 2021 | 02:51h | UTC

The management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: key points from the ESC 2020 Clinical Practice Guidelines for the general and emergency physician – Clinical Medicine Journal

 


M-A: Fracture risk is lower in patients anticoagulated with NOACs compared to patients treated with warfarin

26 Mar, 2021 | 08:26h | UTC

Fracture Risks in Patients Treated With Different Oral Anticoagulants: A Systematic Review and Meta‐Analysis – Journal of the American Heart Association

Commentary: NOACs associated with a 16% lower risk of bone fractures than warfarin – Cardiovascular Business

 


Ultra-Processed Foods and Incident Cardiovascular Disease in the Framingham Offspring Study

24 Mar, 2021 | 08:02h | UTC

Ultra-Processed Foods and Incident Cardiovascular Disease in the Framingham Offspring Study – Journal of the American College of Cardiology

Commentaries: Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk – TCTMD AND Ultra-Processed Foods and Incident Cardiovascular Disease – American College of Cardiology

 


Natural Course of New‐Onset Postoperative Atrial Fibrillation after Noncardiac Surgery

23 Mar, 2021 | 02:00h | UTC

Natural Course of New‐Onset Postoperative Atrial Fibrillation after Noncardiac Surgery – Journal of the American Heart Association

 


Long-term outcomes of patients undergoing the Ross procedure

21 Mar, 2021 | 21:42h | UTC

Long-Term Outcomes of Patients Undergoing the Ross Procedure – Journal of the American College of Cardiology

Commentaries: Ross Procedure Done Well Holds Up Over Time – TCTMD AND Long-Term Outcomes of the Ross Procedure – American College of Cardiology

 


Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review

21 Mar, 2021 | 21:49h | UTC

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review – Journal of the American College of Cardiologyv

 

Commentary on Twitter

 


Cohort study: Fish consumption linked to reduced risk of major cardiovascular complications among patients with prior cardiovascular disease, but not in the general population

19 Mar, 2021 | 08:03h | UTC

Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 Countries – JAMA Internal Medicine (link to abstract – $ for full-text)

Commentary: Study finds two servings of fish per week can help prevent recurrent heart disease – McMaster University

Author interview: Fish Consumption and Risk of Cardiovascular Disease or Mortality With or Without Vascular Disease

 

 


Cover Story | Interventional Management in Acute Type B and Type A Aortic Dissection

19 Mar, 2021 | 08:04h | UTC

Cover Story | Interventional Management in Acute Type B and Type A Aortic Dissection – Cardiology Magazine / American College of Cardiology

 


Video: Coronavirus Update with Carlos del Rio and Preeti Malani

19 Mar, 2021 | 08:24h | UTC

Coronavirus Update With Carlos del Rio and Preeti Malani – JAMA

 


Five-year outcomes of PFO closure or antiplatelet therapy for cryptogenic stroke

17 Mar, 2021 | 02:40h | UTC

PFO Closure for Stroke Is Safe, Effective at 5 Years: REDUCE – TCTMD

Original study: Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke – New England Journal of Medicine ($)

 


RCT: No benefit from marine Omega-3 fatty acid and Vitamin D supplementation on incident atrial fibrillation

17 Mar, 2021 | 02:38h | UTC

Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Omega-3 Fatty Acids and Atrial Fibrillation – JAMA (free for a limited period)

 


Opinion | Cardiovascular harm from egg yolk and meat: More than just cholesterol and saturated fat

17 Mar, 2021 | 02:35h | UTC

Cardiovascular Harm From Egg Yolk and Meat: More Than Just Cholesterol and Saturated Fat – Journal of the American Heart Association

 


Consensus Document: Management of acute myocarditis and chronic inflammatory cardiomyopathy

17 Mar, 2021 | 02:28h | UTC

Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document – Circulation: Heart Failure

 


COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies

17 Mar, 2021 | 02:52h | UTC

COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies – Cochrane Library

 

Commentary on Twitter

 


Meta-analysis of randomized trials bring into question the belief that betablockers cause depression

16 Mar, 2021 | 01:47h | UTC

Do β-Blockers Cause Depression? Systematic Review and Meta-Analysis of Psychiatric Adverse Events During β-Blocker Therapy – Hypertension (link to abstract – $ for full-text)

News release: Beta-blockers not likely to cause depression yet may contribute to sleep disturbances – American Heart Association

Commentary: Beta blockers not associated with risk of depression – Charité – Universitätsmedizin Berlin

 


Platelet tests pre-CABG may safely shorten washout waits, cut costs

16 Mar, 2021 | 01:44h | UTC

Platelet Tests Pre-CABG May Safely Shorten Washout Waits, Cut Costs – TCTMD

Original study: Platelet Reactivity in Patients With Acute Coronary Syndromes Awaiting Surgical Revascularization – Journal of the American College of Cardiology

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.